An intradermal fluid delivery device that uses a processor controlled electromechanical delivery mechanism is provided. An air pump pushes fluid containing medication or saline from a fluid compartment through a microneedle array into a person's skin. The processor repeatedly turns the air pump on or off, for the fluid to gradually be injected into the person's skin. The processor may be configured to control the total fluid delivery time as well as the granularity of the fluid delivery. The total fluid delivery time may be set to T, and the time period T may be divided into smaller periods t.sub.1 to t.sub.n, where the fluid may be administered in a period t1, the fluid delivery may then be stopped for a period t2, followed by another fluid delivery period, etc. The periods t1 to tn may be the same or of different lengths.

An intravenous (IV) fluid delivery system include an IV bag and a fluid delivery device. The IV bag is made of many fluidic channels that keep the fluid distributed across the bag such that the bag may be easily and comfortably wrapped around the arm and shoulder of a person. The fluid delivery device includes a processor controlled electromechanical delivery mechanism that controls a positive displacement pump. The pump moves the fluid into a tube and a needle that is connected to a person's vein. The processor repeatedly turns the pump on or off to gradually transfer the fluid from the IV bag into the person's vein. The processor controls the granularity of the fluid delivery, where the fluid may be administered in a fluid delivery period, the fluid delivery may then be stopped in a subsequent fluid stoppage period, followed by other fluid delivery periods.

A shield assembly for a syringe includes a cradle, a carriage, and a shield. The cradle is configured to be operatively engaged around a portion of a circumference of a syringe barrel. The shield is configured to extend longitudinally outwardly from the cradle to cover a needle of the syringe. The carriage secures the shield to the cradle and is configured to be movably engaged with the cradle. The shield is detachably engaged with the carriage and is configured to be aesthetically pleasing to a young child. The shield assembly is engaged with the syringe prior to use so as to reduce stress in the young child while they are either being injected with a substance or having their blood drawn. After the procedure, the shield may be detached from the shield assembly and may be given to the young patient.

An arm support for intravenous medical treatments includes an arm support portion having a first surface and a second surface that defines a rigid support receiving zone. The first surface includes a cushioned section. At least one strap member is secured to the arm support portion. A rigid support member is positioned at the second surface at the rigid support receiving zone.

An accessory attachment mechanism for a wagon is provided. The mechanism has a mounting bracket, a pivot arm, and a retention mechanism. The mounting bracket is connected to the wagon and has a first opening, a second opening, and a pivot member. The pivot arm is pivotally connected to the mounting bracket at the pivot member and pivots about a plane generally parallel to a base of the wagon between a storage position and a use position. A pin extends through the pivot arm into separate openings in the mounting bracket to retain the pivot arm in the storage and use positions. The retention mechanism is provided at an end of the pivot arm and has a moveable clamp member adapted to secure an accessory thereto.

An intravenous (IV) fluid delivery system include an IV bag and a fluid delivery device. The IV bag is made of many fluidic channels that keep the fluid distributed across the bag such that the bag may be easily and comfortably wrapped around the arm and shoulder of a person. The fluid delivery device includes a processor controlled electromechanical delivery mechanism that controls a positive displacement pump. The pump moves the fluid into a tube and a needle that is connected to a person's vein. The processor repeatedly turns the pump on or off to gradually transfer the fluid from the IV bag into the person's vein. The processor controls the granularity of the fluid delivery, where the fluid may be administered in a fluid delivery period, the fluid delivery may then be stopped in a subsequent fluid stoppage period, followed by other fluid delivery periods.

A nasal delivery device for and method of delivering a substance, preferably comprising oxytocin, non-peptide agonists thereof and antagonists thereof, preferably as one of a liquid, as a suspension or solution, or a powder, to the nasal airway of a subject, preferably the posterior region of the nasal airway, and preferably the upper posterior region of the nasal airway which includes the olfactory bulb and the trigeminal nerve, and preferably in the treatment of neurological conditions and disorders.

A facemask includes a facemask body, a plurality of electrical contacts and a control circuit. The facemask body has an end including an opening and a skin contact perimeter extending along a periphery of the opening, with the skin contact perimeter configured to sealingly engage with a user's face. Each electrical contact is disposed at a respective region of the skin contact perimeter, and each electrical contact is configured to sense when the respective region of the skin contact perimeter is sealingly engaged with a user's face. The control circuit is disposed on the facemask body, and the control circuit is configured to receive a signal from each electrical contact when the respective region of the skin contact perimeter is sealingly engaged with a user's face and to initiate output of an audible stimulus and/or a visual stimulus in response to receiving a concurrent signal from all of the plurality of electrical contacts.

The disclosed invention provides a skin therapy system for skin conditioning or treatment of a body part. The skin therapy system includes a body part shaped encaser including a first and second film substrate and an encaser liner disposed between the first and second film substrates. An outer peripheral edge of the encaser liner is sealed between outer peripheral edges of the first and second film substrates to create a hermetic seal forming a first fillable space between the first film substrate and a first layer of the encaser liner, a second fillable space between the second film substrate and a second layer of the encaser liner, and an internal volume defined by the first and second layers of the encaser liner and disposed between the first and second fillable spaces. The skin therapy system further includes a therapeutic composition contained within the first and second fillable spaces.

A method of creating a custom color adhesive securement arrangement for use with a patient interface includes performing a scan of a patient's face, extracting color values of a portion of the patient's face from the scan, determining one or more colors based on the extracted color values, obtaining an adhesive sheet having the one or more colors, and cutting the securement arrangement from the adhesive sheet.